Essentially pure preparations of normal density eosinophils obtained from patients with hypereosinophilic syndrome (HES) were stimulated with complement factor 5a (C5a), platelet-activating factor (PAF), FMLP and neutrophil-activating peptide (NAP-1/IL-8). Three responses were studied, the transient rise in cytosolic free calcium concentration (ICa2+j (derived from indo-1 fluorescence), shape changes (measured by laser turbidimetry), and exocytosis of eosinophil peroxidase (EPO) (assessed by H202/luminol-dependent chemiluminescence). Responses were obtained with all four agonists, but C5a and PAF were by far more potent than FMLP and NAP-1/IL-8, which induced only minor effects. Pretreatment of the cells with pertussis toxin attenuated ICa2+h changes, EPO release and, to a lesser extent, shape changes, indicating that GTP-binding proteins of Gi-type are involved in receptor-dependent signal transduction processes leading to these responses. A clear dissociation was observed in the control of the shape change response and EPO exocytosis. The shape change was not affected by Ca2' depletion or treatment with the protein kinase inhibitor staurosporine, but exocytosis was prevented by Ca2' depletion and markedly enhanced by staurosporine. The activation of the contractile system, leading to shape changes and motility, thus appears to be independent of the classical signal transduction pathway involving phospholipase C, a [Ca2j11 rise and protein kinase C activation. Exocytosis is, as expected, CIO+ dependent and appears to be under a negative control involving protein phosphorylations. (J. Clin. Invest.
Introduction
Eosinophils are specialized proinflammatory cells found in the blood and tissues that play an important role in host defence and disease (1) (2) (3) . They increase in number and become activated in a variety of parasitic, allergic, and inflammatory disorders (4) , and respond to different stimuli by a selective release t Deceased.
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Receivedforpublication 2 May 1990 and in revisedform 4 February 1991. of their granule proteins (5) . The cDNA encoding four highly basic and cytotoxic granule proteins: eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase (EPO)', and major basic protein, have recently been cloned and sequenced (6) (7) (8) (9) . The cytokines IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF), which control eosinophil differentiation, activation, and secretion have also been characterized, cloned, and sequenced (10) . Despite this rapidly advancing knowledge in the molecular and cellular biology of the eosinophils, little is known about the transmembrane signaling pathways that transmit information from the outside to the cell interior as a result ofagonist-receptor interaction. Eosinophils share several properties with other granulocytes, neutrophils in particular, as they perform chemotaxis and phagocytosis, and secrete granular contents into phagocytic vacuoles and the extracellular medium (11, 12) . Some of the biochemical mechanisms involved in signal transduction pathways activated by receptor-agonist binding have been described in neutrophils (13) (14) (15) (16) (17) (18) . It is not clear whether eosinophil responses are dependent on signal transduction mechanisms similar to those found in neutrophils.
We have now studied some ofthe postreceptor events leading to shape changes and EPO secretion in human blood eosinophils from patients with the hypereosinophilic syndrome (HES), stimulated with complement factor 5a (C5a), plateletactivating factor (PAF), FMLP, or neutrophil-activating peptide (NAP-1)/IL-8. Pertussis toxin prevented EPO exocytosis and the cytosolic free calcium concentration ([Ca2+]i) changes, but inhibited the shape changes only in part, suggesting a different regulation ofthese responses. Again in contrast to exocytosis, the shape change was independent ofCa2" and thus appears to be dissociated from the classical signal transduction pathway involving phospholipase C and protein kinase C.
Methods
Materials. Materials were purchased from sources described elsewhere ( 18) Ca2' depleted eosinophils were obtained by incubating I07 cells/mI with 10 M ofthe Ca2' chelator quin2/AM in test medium containing 2 mM EGTA instead of 1 mM Ca2+ for 30 min at 370C.
B. pertussis toxin treatment was performed by incubation of 1 X 107 eosinophils/ml for 90 min at 370C with and without 2 Mg/ml pertussis toxin. The cells were then washed and resuspended in test medium.
Exocytosis. The release of EPO was measured by luminol-dependent chemiluminescence using a modification of the method of Carlson et al. (26) . Suspensions of 2 x 10' eosinophils were preincubated for 4 min at 370C in 1 ml of test buffer supplemented with 100 M luminol, 200 AM H202, and 5Mug ofcytochalasin B and then stimulated by agonist addition. No release of EPO was observed in the absence of cytochalasin B. Emitted light, proportional to the total amount of released EPO, was digitally recorded at time intervals of 200 ms. The proportionality between emitted light and released EPO is progressively lost by inactivation ofthe peroxidase, e.g., by dimerization (27 Figure 2 . Light transmission changes of eosinophil suspensions (8 X I0O cells/ml) stimulated at time zero by maximum effective agonist concentrations (10 nM C5a, 100 nM PAF, NAP-1/IL-8 or FMLP).
The tracings are displaced along the ordinate for better readability. The initial transmission values were between 15 and 25%, and the bar represents a relative transmission change of 1%. (Fig. 6 ). By contrast, under the same conditions, staurosporine did not alter the increase in light transmission that reflects shape changes (Fig. 6) . A slight prolongation of this response was observed in the presence of the kinase inhibitor. (34) . In neutrophils, Ca2' depletion prevents the formation of inositol trisphosphate, presumably through inactivation of the phosphatidylinositol-specific phospholipase C (35) . Under these conditions the stimulus-dependent formation of filamentous actin remains unaffected (36) , indicating that phospholipase C is not involved in the control of the motile response (34) . According to these results, much the same conclusions can be drawn for eosinophils. In view ofthis similarity between the two cell types, it was surprising to observe that the shape change response induced in eosinophils by C5a and PAF was only partially inhibited by pertussis toxin. In human neutrophils, under otherwise identical conditions, half of the toxin concentration used in these experiments was sufficient to prevent the rise in [Ca2+]i, the exocytosis of elastase, and the shape changes induced by chemotactic peptide agonists (34, 37) , suggesting that the amount of toxin was sufficient for exhaustive ADP-ribosylation. On the basis ofthe susceptibility to pertussis toxin, Verghese et al. (31) suggested that agonistdependent [Ca2]i changes may be partly induced via a toxinresistant process when the bioactive lipids, LTB4 and PAF (in contrast to fMLP), are used as stimuli. Using PAF but not peptide agonists, we also observed only partial inhibition of shape and [Caj]i changes by pertussis toxin pretreatment in human neutrophils (Kernen, P., unpublished results). These data clearly establish a role for pertussis toxin-inhibitable G,.-proteins in the induction ofeosinophil shape changes by stimulation with C5a or PAF. A more detailed study on the effects of pertussis toxin oneosinophil responses will be needed to elucidate a possible role of G-proteins which are not available for ADP-ribosylation or other mechanisms bypassing Gij-proteins.
In contrast to the shape change response, exocytosis and the Agonist-induced exocytosis of EPO in cytochalasin Btreated eosinophils was markedly enhanced by staurosporine. These results are similar to these obtained in neutrophils, where staurosporine by itself induced specific granule release and inhibited PMA-and FMLP-modulated phosphorylation of 48-kD proteins (28) . Although staurosporine may have other effects (40) (41) (42) (43) including (at high concentrations) inhibition of cyclic nucleotide-dependent kinases (44) , it is an effective inhibitor of phospholipid/Ca2" dependent protein kinase 
C (PKC) (45-49).
Together with the present results, this indicates, that PKC activity plays a minor role in agonist-induced EPO release, which is in agreement with interpretations based on experiments with H-7 or C-l in neutrophils (50) (51) (52) . The unexpected, staurosporine-dependent increase in EPO release seems to be decoupled from PKC-mediated protein phosphorylation. Interestingly, it has also been reported that staurosporine, like phorbol esters and diacylglycerols, induces the translocation of protein kinase C to membranes (49) .
In contrast to the respiratory burst, which was totally inhibited by 100 nM staurosporine (Wymann, M. P., V. von Tscharner, P. C. Tai, C. J. Spry, P. Kernen, and M. Baggiolini, manuscript in preparation), the early phases of PAF-and C5a-induced shape changes were not affected, although the response was slightly prolonged. This further supports the conclusion from Ca2" depletion experiments, that PKC is not involved in rapid morphologic changes.
A further evidence for a modulation of eosinophil responses by protein kinase C is provided by the observation that the extent of the [Ca2+]i rise induced by C5a and PAF was decreased by PMA. Downregulating effects ofprotein kinase C have been observed in other cell types. Phorbol ester or 1,2-diacylglycerol pretreatment ofhuman platelets inhibited the production of inositol phosphates (53) , suggesting a feedback control ofsecond messenger generation by protein kinase C. PMAactivated protein kinase C in human neutrophils enhanced diacylglycerol formation through the hydrolysis of a substrate other than phosphatidylinositol 4,5-bisphosphate, e.g., phosphatidylcholine (29, 54 (55) , who observed the activation of an inositol trisphosphate 5'-phosphomonoesterase by protein kinase C. The fact that some G-proteins (e.g., the alpha-subunit of transducin or Gprotein coupled to the beta-adrenergic receptor kinase) are conformation-dependent substrates for protein kinase C suggests that once activated this kinase may have a regulatory effect even on earlier events of the signal transduction sequence (56) .
This comparative study shows that PAF and C5a are powerful stimuli for human eosinophils, and that only minor effects are obtained with FMLP and NAP-1/IL-8. PAF, which has been studied most exclusively, is chemotactic for eosinophils from both normal (57, 58) and hypereosinophilic individuals (59) and induces the release of EPO and eosinophil cationic protein (39) . The low effectiveness of NAP-1/IL-8 on eosinophil shape change activity as compared with neutrophils (37) is in agreement with the observation that despite massive neutrophil accumulation (60), virtually no eosinophils are found after intradermal administration of NAP-1/IL-8 in animals. NAP-1/IL-8 also lacks stimulating or priming effects on secretion of eosinophil cationic protein in isolated eosinophils (Tai, P. C., and C. J. Spry, manuscript in preparation), and can thus be ruled out as a mediator of eosinophil diapedesis and function.
While neutrophils respond with similar degree to all four of the stimuli used in this study, the higher agonist selectivity exhibited by eosinophils is likely to determine the type ofpathophysiology that is associated with eosinophilia (61). It is well established that eosinophils from patients with HES are more responsive to stimulation than blood eosinophils from normal individuals. They have increased metabolic (62) , secretory (63) , and cytotoxic capacities (49, 64), and are thus similar to tissue eosinophils (65) . However, normal blood eosinophils can be primed by cytokines like GM-CSF, IL-3, and IL-5 to acquire the responsiveness of HES eosinophils (66) (67) (68) 
